These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 28701225)

  • 1. Association of schizophrenia onset age and white matter integrity with treatment effect of D-cycloserine: a randomized placebo-controlled double-blind crossover study.
    Takiguchi K; Uezato A; Itasaka M; Atsuta H; Narushima K; Yamamoto N; Kurumaji A; Tomita M; Oshima K; Shoda K; Tamaru M; Nakataki M; Okazaki M; Ishiwata S; Ishiwata Y; Yasuhara M; Arima K; Ohmori T; Nishikawa T
    BMC Psychiatry; 2017 Jul; 17(1):249. PubMed ID: 28701225
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sarcosine or D-serine add-on treatment for acute exacerbation of schizophrenia: a randomized, double-blind, placebo-controlled study.
    Lane HY; Chang YC; Liu YC; Chiu CC; Tsai GE
    Arch Gen Psychiatry; 2005 Nov; 62(11):1196-204. PubMed ID: 16275807
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Cognitive and Negative Symptoms in Schizophrenia Trial (CONSIST): the efficacy of glutamatergic agents for negative symptoms and cognitive impairments.
    Buchanan RW; Javitt DC; Marder SR; Schooler NR; Gold JM; McMahon RP; Heresco-Levy U; Carpenter WT
    Am J Psychiatry; 2007 Oct; 164(10):1593-602. PubMed ID: 17898352
    [TBL] [Abstract][Full Text] [Related]  

  • 4. D-Cycloserine added to risperidone in patients with primary negative symptoms of schizophrenia.
    Evins AE; Amico E; Posever TA; Toker R; Goff DC
    Schizophr Res; 2002 Jul; 56(1-2):19-23. PubMed ID: 12084415
    [TBL] [Abstract][Full Text] [Related]  

  • 5. D-cycloserine increases positive symptoms in chronic schizophrenic patients when administered in addition to antipsychotics: a double-blind, parallel, placebo-controlled study.
    van Berckel BN; Evenblij CN; van Loon BJ; Maas MF; van der Geld MA; Wynne HJ; van Ree JM; Kahn RS
    Neuropsychopharmacology; 1999 Aug; 21(2):203-10. PubMed ID: 10432468
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A placebo-controlled trial of D-cycloserine added to conventional neuroleptics in patients with schizophrenia.
    Goff DC; Tsai G; Levitt J; Amico E; Manoach D; Schoenfeld DA; Hayden DL; McCarley R; Coyle JT
    Arch Gen Psychiatry; 1999 Jan; 56(1):21-7. PubMed ID: 9892252
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A six-month, placebo-controlled trial of D-cycloserine co-administered with conventional antipsychotics in schizophrenia patients.
    Goff DC; Herz L; Posever T; Shih V; Tsai G; Henderson DC; Freudenreich O; Evins AE; Yovel I; Zhang H; Schoenfeld D
    Psychopharmacology (Berl); 2005 Apr; 179(1):144-50. PubMed ID: 15502972
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A multicenter, add-on randomized controlled trial of low-dose d-serine for negative and cognitive symptoms of schizophrenia.
    Weiser M; Heresco-Levy U; Davidson M; Javitt DC; Werbeloff N; Gershon AA; Abramovich Y; Amital D; Doron A; Konas S; Levkovitz Y; Liba D; Teitelbaum A; Mashiach M; Zimmerman Y
    J Clin Psychiatry; 2012 Jun; 73(6):e728-34. PubMed ID: 22795211
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dose-finding trial of D-cycloserine added to neuroleptics for negative symptoms in schizophrenia.
    Goff DC; Tsai G; Manoach DS; Coyle JT
    Am J Psychiatry; 1995 Aug; 152(8):1213-5. PubMed ID: 7625475
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A placebo-controlled crossover trial of D-cycloserine added to clozapine in patients with schizophrenia.
    Goff DC; Henderson DC; Evins AE; Amico E
    Biol Psychiatry; 1999 Feb; 45(4):512-4. PubMed ID: 10071726
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of D-cycloserine on negative symptoms in schizophrenia.
    Duncan EJ; Szilagyi S; Schwartz MP; Bugarski-Kirola D; Kunzova A; Negi S; Stephanides M; Efferen TR; Angrist B; Peselow E; Corwin J; Gonzenbach S; Rotrosen JP
    Schizophr Res; 2004 Dec; 71(2-3):239-48. PubMed ID: 15474895
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Extensive white matter abnormalities and clinical symptoms in drug-naive patients with first-episode schizophrenia: a voxel-based diffusion tensor imaging study.
    Zhang XY; Fan FM; Chen DC; Tan YL; Tan SP; Hu K; Salas R; Kosten TR; Zunta-Soares G; Soares JC
    J Clin Psychiatry; 2016 Feb; 77(2):205-11. PubMed ID: 26761708
    [TBL] [Abstract][Full Text] [Related]  

  • 13. White Matter Abnormalities in Never-Treated Patients With Long-Term Schizophrenia.
    Xiao Y; Sun H; Shi S; Jiang D; Tao B; Zhao Y; Zhang W; Gong Q; Sweeney JA; Lui S
    Am J Psychiatry; 2018 Nov; 175(11):1129-1136. PubMed ID: 30068259
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Paradoxical Relationship between White Matter, Psychopathology and Cognition in Schizophrenia: A Diffusion Tensor and Proton Spectroscopic Imaging Study.
    Caprihan A; Jones T; Chen H; Lemke N; Abbott C; Qualls C; Canive J; Gasparovic C; Bustillo JR
    Neuropsychopharmacology; 2015 Aug; 40(9):2248-57. PubMed ID: 25786581
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Placebo-controlled trial of D-cycloserine added to conventional neuroleptics, olanzapine, or risperidone in schizophrenia.
    Heresco-Levy U; Ermilov M; Shimoni J; Shapira B; Silipo G; Javitt DC
    Am J Psychiatry; 2002 Mar; 159(3):480-2. PubMed ID: 11870017
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative effects of glycine and D-cycloserine on persistent negative symptoms in schizophrenia: a retrospective analysis.
    Heresco-Levy U; Javitt DC
    Schizophr Res; 2004 Feb; 66(2-3):89-96. PubMed ID: 15061240
    [TBL] [Abstract][Full Text] [Related]  

  • 17. D-alanine added to antipsychotics for the treatment of schizophrenia.
    Tsai GE; Yang P; Chang YC; Chong MY
    Biol Psychiatry; 2006 Feb; 59(3):230-4. PubMed ID: 16154544
    [TBL] [Abstract][Full Text] [Related]  

  • 18. D-cycloserine added to clozapine for patients with schizophrenia.
    Goff DC; Tsai G; Manoach DS; Flood J; Darby DG; Coyle JT
    Am J Psychiatry; 1996 Dec; 153(12):1628-30. PubMed ID: 8942463
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Abnormal white matter microstructure in drug-naive first episode schizophrenia patients before and after eight weeks of antipsychotic treatment.
    Zeng B; Ardekani BA; Tang Y; Zhang T; Zhao S; Cui H; Fan X; Zhuo K; Li C; Xu Y; Goff DC; Wang J
    Schizophr Res; 2016 Apr; 172(1-3):1-8. PubMed ID: 26852402
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A randomized, double-blind, placebo-controlled comparison study of sarcosine (N-methylglycine) and D-serine add-on treatment for schizophrenia.
    Lane HY; Lin CH; Huang YJ; Liao CH; Chang YC; Tsai GE
    Int J Neuropsychopharmacol; 2010 May; 13(4):451-60. PubMed ID: 19887019
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.